9II.F
Healthcare BiotechnologyBiovica International AB (publ)
€0.02
-0.00 -1.23% today Live
Price History
Not enough data
| Date | Price |
|---|---|
| Oct 7, 2026, live at 2:43 PM ET | 0.02 |
Key Stats
Market Cap
4.67M
Avg Volume
303
EPS
-€0.02
52W High
€0.04
52W Low
€0.00
Div. Yield
0.0%
Valuation
P/B Ratio
0.06
Margins
Gross Margin 96.9%
Operating Margin 0.0%
Net Margin 0.0%
EBITDA Margin 0.0%
Growth & Returns
Revenue Growth (YoY)
55.8%
Return on Equity
(156.6%)
Return on Assets
(60.9%)
Liquidity & Leverage
Current Ratio
3.06
Quick Ratio
2.95
Debt / Equity
0.09
About
Biovica International AB (publ), a biotech company, develops and commercializes blood-based biomarker assays for oncologists monitor cancer progression in the European Union, the United States, and Asia. The company engages in the development of DiviTum TKa, a monitoring tool for patients with early or metastatic breast cancer undergoing treatment with CDK4/6 inhibitors. It serves cancer institutes and pharmaceutical companies. The company was incorporated in 2008 and is headquartered in Uppsala, Sweden.
www.biovica.com